Overview
BOAN BIOTECH (6955)
Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo...
- Open
- 3.165
- High
- 3.165
- Low
- 2.985
- Prev. Close
- 3.100
- Volume
- 428.40K
- Turnover
- 1.30M
- Avg Price
- 3.042
- Bid/Ask Ratio
- -60.66%
- Amplitude
- 5.81%
- 52wk High
- 11.200
- Volume Ratio
- 0.06
- Turnover Ratio
- 0.07%
- 52wk Low
- 2.400
- HK Mkt Cap
- 1.91B
- Market CapHKD
- 1.91B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.181
- EPSDynamic
- -0.311
- EPSStatic
- --
- BVPS
- 4.99
- P/B
- 0.62
- HK Shares
- 613.63M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 613.63M
- Min lot size
- 200
- Currency
- HKD
BOAN BIOTECH Analyst Rating
View moreForecast & Rating
Jul 25, 2025- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 0
- Buy
- 0
- Hold
- 1
- Sell
- 0
- Strong sell
- 0
Daily Events
- Jul, 3
Shandong Boan Biotechnology (6955.HK) staged a rally from a low open, surging in the afternoon session to close up 7.14% at HKD 5.10, driven by positive clinical and licensing news. The company received CDE approval for a Phase II lung cancer trial of a novel immunotherapy combo, while its dulaglutide injection was licensed in the US and two denosumab biosimilar BLAs were submitted to the US FDA, marking key R&D milestones. However, fundamentals remain under pressure: Q4 2025 revenue rose 12.59% YoY to HKD 217.6 million, but net profit swung to a loss of HKD 7.43 million, with EPS down 218.36% YoY. The stock is still 74.37% below its 52-week high of HKD 19.9 and down 37.8% YTD; while it has reclaimed the 20-day MA (HKD 4.828), it remains well below the 60-day MA (HKD 5.985), highlighting persistent valuation concerns.
News
PUBT · Shandong Boan Wins China Approval to Begin BA2201 Clinical Trials
Market Movers · 博安生物涨约 6%。
PUBT · Smoore International Discloses Share Buyback in HKEX Next-Day Return
PUBT · Shandong Boan Signs Licensing Deal for Denosumab in Japan
PUBT · Smoore International Files HKEX Next Day Disclosure Return Announcing Share Buyback
